Published in J Clin Endocrinol Metab on May 01, 2001
Risk of cancer in a large cohort of nonaspirin NSAID users: a population-based study. Br J Cancer (2003) 2.43
The effect of HIV and HPV coinfection on cervical COX-2 expression and systemic prostaglandin E2 levels. Cancer Prev Res (Phila) (2011) 1.85
COX-2 expression is associated with an aggressive phenotype in ductal carcinoma in situ. Br J Cancer (2004) 1.59
E-type prostanoid receptor 4 (EP4) in disease and therapy. Pharmacol Ther (2013) 1.28
Cyclooxygenase-1 is up-regulated in cervical carcinomas: autocrine/paracrine regulation of cyclooxygenase-2, prostaglandin e receptors, and angiogenic factors by cyclooxygenase-1. Cancer Res (2002) 1.20
A novel angiogenic role for prostaglandin F2alpha-FP receptor interaction in human endometrial adenocarcinomas. Cancer Res (2005) 1.20
Resveratrol interferes with AKT activity and triggers apoptosis in human uterine cancer cells. Mol Cancer (2006) 1.18
Cyclooxygenase enzymes and prostaglandins in pathology of the endometrium. Reproduction (2003) 1.12
Activation of lipid metabolism contributes to interleukin-8 production during Chlamydia trachomatis infection of cervical epithelial cells. Infect Immun (2005) 1.07
Characterization of novel radicals from COX-catalyzed arachidonic acid peroxidation. Free Radic Biol Med (2009) 1.01
Celecoxib induces apoptosis in cervical cancer cells independent of cyclooxygenase using NF-kappaB as a possible target. J Cancer Res Clin Oncol (2004) 0.97
Prostaglandin E2 and F2alpha activate the FP receptor and up-regulate cyclooxygenase-2 expression via the cyclic AMP response element. Mol Cell Endocrinol (2008) 0.94
CD3zeta expression and T cell proliferation are inhibited by TGF-beta1 and IL-10 in cervical cancer patients. J Clin Immunol (2009) 0.91
Interleukin-1beta induces glycosaminoglycan synthesis via the prostaglandin E2 pathway in cultured human cervical fibroblasts. Mol Hum Reprod (2003) 0.90
Chorionic gonadotrophin regulates CXCR4 expression in human endometrium via E-series prostanoid receptor 2 signalling to PI3K-ERK1/2: implications for fetal-maternal crosstalk for embryo implantation. Mol Hum Reprod (2010) 0.87
Seminal plasma activates cyclooxygenase-2 and prostaglandin E2 receptor expression and signalling in cervical adenocarcinoma cells. Mol Hum Reprod (2002) 0.85
Characterization of free radicals formed from COX-catalyzed DGLA peroxidation. Free Radic Biol Med (2011) 0.85
Loss of the EP2 prostaglandin E2 receptor in immortalized human keratinocytes results in increased invasiveness and decreased paxillin expression. Am J Pathol (2002) 0.84
Visceral fat adipocytes from obese and colorectal cancer subjects exhibit distinct secretory and ω6 polyunsaturated fatty acid profiles and deliver immunosuppressive signals to innate immunity cells. Oncotarget (2016) 0.82
The roles of beta-adrenergic receptors in tumorigenesis and the possible use of beta-adrenergic blockers for cancer treatment: possible genetic and cell-signaling mechanisms. Cancer Manag Res (2012) 0.81
An advanced Electron Spin Resonance (ESR) spin-trapping and LC/(ESR)/MS technique for the study of lipid peroxidation. Int J Mol Sci (2012) 0.81
Estradiol-17beta, prostaglandin E2 (PGE2), and the PGE2 receptor are involved in PGE2 positive feedback loop in the porcine endometrium. Endocrinology (2009) 0.81
Free radical derivatives formed from cyclooxygenase-catalyzed dihomo-γ-linolenic acid peroxidation can attenuate colon cancer cell growth and enhance 5-fluorouracil's cytotoxicity. Redox Biol (2014) 0.80
Pathological function of prostaglandin E2 receptors in transitional cell carcinoma of the upper urinary tract. Virchows Arch (2006) 0.79
Seminal plasma enhances cervical adenocarcinoma cell proliferation and tumour growth in vivo. PLoS One (2012) 0.78
Effects of Tetrahydrocurcumin on Tumor Growth and Cellular Signaling in Cervical Cancer Xenografts in Nude Mice. Biomed Res Int (2016) 0.77
Seminal plasma induces the expression of IL-1α in normal and neoplastic cervical cells via EP2/EGFR/PI3K/AKT pathway. J Mol Signal (2014) 0.77
GW627368X inhibits proliferation and induces apoptosis in cervical cancer by interfering with EP4/EGFR interactive signaling. Cell Death Dis (2016) 0.77
Medical Application of Spirulina platensis Derived C-Phycocyanin. Evid Based Complement Alternat Med (2016) 0.75
The regulation of inflammatory pathways and infectious disease of the cervix by seminal fluid. Patholog Res Int (2014) 0.75
Seminal Fluid-Mediated Inflammation in Physiology and Pathology of the Female Reproductive Tract. J Immunol Res (2016) 0.75
Prostaglandin E2 (PGE2) promotes proliferation and invasion by enhancing SUMO-1 activity via EP4 receptor in endometrial cancer. Tumour Biol (2016) 0.75
The Prostaglandin EP3 Receptor Is an Independent Negative Prognostic Factor for Cervical Cancer Patients. Int J Mol Sci (2017) 0.75
Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell (1996) 7.46
Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell (1998) 7.25
Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell (1995) 6.69
Human cyclooxygenase-2 cDNA. Proc Natl Acad Sci U S A (1992) 5.21
International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacol Rev (1994) 5.11
Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci U S A (1997) 4.84
The causal link between human papillomavirus and invasive cervical cancer: a population-based case-control study in Colombia and Spain. Int J Cancer (1992) 3.88
Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells. Cancer Res (1998) 3.79
Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing. Nat Med (1999) 3.57
Prostaglandin synthase 2. Biochim Biophys Acta (1996) 3.14
Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. Cancer Res (1998) 3.11
Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer. Cancer Res (1999) 3.00
Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2. J Clin Invest (1997) 2.99
Expression of cyclooxygenase-2 in human lung carcinoma. Cancer Res (1998) 2.92
Cyclooxygenase-2 expression in human esophageal carcinoma. Cancer Res (1999) 2.51
Over-expression of cyclooxygenase-2 in human prostate adenocarcinoma. Prostate (2000) 2.19
Prostaglandin endoperoxide synthase: regulation of enzyme expression. Biochim Biophys Acta (1991) 2.19
Arachidonic acid is preferentially metabolized by cyclooxygenase-2 to prostacyclin and prostaglandin E2. J Biol Chem (1999) 1.65
Inhibition of cyclooxygenase-2 gene expression by p53. J Biol Chem (1999) 1.62
Expression of cyclooxygenase-2 (COX-2) in human invasive transitional cell carcinoma (TCC) of the urinary bladder. Cancer Res (1999) 1.58
Transcription of cyclooxygenase-2 is enhanced in transformed mammary epithelial cells. Cancer Res (1996) 1.43
Prostaglandin concentrations in the semen of fertile men. J Reprod Fertil (1978) 1.00
Cervical cancer incidence and mortality trends in Finland and Estonia: a screened vs. an unscreened population. Eur J Cancer (1993) 0.96
Co-expression of prostaglandin receptors with opposite effects: a model for homeostatic control of autocrine and paracrine signaling. Biochem Pharmacol (1998) 0.94
Measurement of PGE2 as the methyl oxime by radioimmunoassay using a novel iodinated label. Prostaglandins Leukot Essent Fatty Acids (1989) 0.92
The changing incidence of cervical intra-epithelial neoplasia. S Afr Med J (1990) 0.86
Cervical cytological services in the Orange Free State. Demographic characteristics. S Afr Med J (1989) 0.84
Screening for cancer of the cervix in South Africa. S Afr Med J (1997) 0.82
The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med (1993) 102.56
An immunoglobulin heavy chain variable region gene is generated from three segments of DNA: VH, D and JH. Cell (1980) 10.35
Two mRNAs can be produced from a single immunoglobulin mu gene by alternative RNA processing pathways. Cell (1980) 9.86
Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV. J Hum Hypertens (2004) 8.32
Mechanisms of fear extinction. Mol Psychiatry (2006) 5.44
Identification of the receptor component of the IkappaBalpha-ubiquitin ligase. Nature (1998) 4.89
Antibody diversity: somatic hypermutation of rearranged VH genes. Cell (1981) 4.65
Geobacter sulfurreducens sp. nov., a hydrogen- and acetate-oxidizing dissimilatory metal-reducing microorganism. Appl Environ Microbiol (1994) 4.44
Campylobacter pyloridis and associated gastritis: investigator blind, placebo controlled trial of bismuth salicylate and erythromycin ethylsuccinate. Br Med J (Clin Res Ed) (1986) 4.16
Activation of the left amygdala to a cognitive representation of fear. Nat Neurosci (2001) 3.71
A protein kinase homologue controls phosphorylation of ganciclovir in human cytomegalovirus-infected cells. Nature (1992) 3.59
Extinction of fear-potentiated startle: blockade by infusion of an NMDA antagonist into the amygdala. J Neurosci (1992) 3.40
High molecular gas fractions in normal massive star-forming galaxies in the young Universe. Nature (2010) 3.18
Definition of subchromosomal intervals around the myotonic dystrophy gene region at 19q. Genomics (1989) 3.16
Similar progression of diabetic retinopathy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: a long-term, randomised, open-label study. Diabetologia (2009) 2.98
Double dissociation between the involvement of the bed nucleus of the stria terminalis and the central nucleus of the amygdala in startle increases produced by conditioned versus unconditioned fear. J Neurosci (1997) 2.90
Determinants of participation in state-of-the-art cancer prevention, early detection/screening, and treatment trials among African-Americans. Cancer Nurs (1993) 2.87
A randomized, controlled trial of foscarnet in the treatment of cytomegalovirus retinitis in patients with AIDS. Ann Intern Med (1991) 2.75
A primary acoustic startle circuit: lesion and stimulation studies. J Neurosci (1982) 2.73
Trends in sexual behaviour among London homosexual men 1998-2003: implications for HIV prevention and sexual health promotion. Sex Transm Infect (2004) 2.72
Fear and anxiety: animal models and human cognitive psychophysiology. J Affect Disord (2000) 2.58
A radiation hybrid map of the rat genome containing 5,255 markers. Nat Genet (1999) 2.54
Mouse Cmu heavy chain immunoglobulin gene segment contains three intervening sequences separating domains. Nature (1980) 2.52
Value of a centralised approach in the management of haematemesis and melaena: experience in a district general hospital. Gut (1990) 2.49
Antibodies to the surface of halothane-altered rabbit hepatocytes in patients with severe halothane-associated hepatitis. N Engl J Med (1980) 2.41
The anti-hepatitis B virus activities, cytotoxicities, and anabolic profiles of the (-) and (+) enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine. Antimicrob Agents Chemother (1992) 2.38
Sustaining safe sex: a longitudinal study of a sample of homosexual men. AIDS (1993) 2.35
Gene for alpha-chain of human T-cell receptor: location on chromosome 14 region involved in T-cell neoplasms. Science (1985) 2.33
Long-term memory is facilitated by cAMP response element-binding protein overexpression in the amygdala. J Neurosci (2001) 2.30
Blocking of acquisition but not expression of conditioned fear-potentiated startle by NMDA antagonists in the amygdala. Nature (1990) 2.17
A point mutation in the human cytomegalovirus DNA polymerase gene confers resistance to ganciclovir and phosphonylmethoxyalkyl derivatives. Antimicrob Agents Chemother (1993) 2.16
Role of the hippocampus, the bed nucleus of the stria terminalis, and the amygdala in the excitatory effect of corticotropin-releasing hormone on the acoustic startle reflex. J Neurosci (1997) 2.09
Extraskeletal Ewing's sarcoma. Cancer (1999) 2.08
Similar risk of malignancy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: findings from a 5 year randomised, open-label study. Diabetologia (2009) 2.04
Provision of vascular surgery in England in 2012. Eur J Vasc Endovasc Surg (2012) 2.02
Inflammatory pseudotumor of the alimentary tract: clinical and surgical experience. J Pediatr Surg (2001) 2.01
Fear-potentiated startle in humans: effects of anticipatory anxiety on the acoustic blink reflex. Psychophysiology (1991) 1.95
Critical roles of kisspeptins in female puberty and preovulatory gonadotropin surges as revealed by a novel antagonist. Endocrinology (2009) 1.91
Gimme 5 fruit, juice, and vegetables for fun and health: outcome evaluation. Health Educ Behav (2000) 1.90
Why do people use paracetamol for suicide? Br Med J (1976) 1.89
Psychobiologic mechanisms of posttraumatic stress disorder. Arch Gen Psychiatry (1993) 1.88
Temporal and spatial association of histone H2A variant hv1 with transcriptionally competent chromatin during nuclear development in Tetrahymena thermophila. Genes Dev (1993) 1.87
Molecular cloning of translocations involving chromosome 15 and the immunoglobulin C alpha gene from chromosome 12 in two murine plasmacytomas. Proc Natl Acad Sci U S A (1982) 1.84
Patients with stable long-standing rheumatoid arthritis continue to deteriorate despite intensified treatment with traditional disease modifying anti-rheumatic drugs--results of the British Rheumatoid Outcome Study Group randomized controlled clinical trial. Rheumatology (Oxford) (2005) 1.84
Severity of alcohol dependence in patients with alcoholic liver disease. Br Med J (Clin Res Ed) (1983) 1.82
Hypersensitivity and jaundice due to azathioprine. Postgrad Med J (1980) 1.81
Use of gay Internet sites and views about online health promotion among men who have sex with men. AIDS Care (2004) 1.77
Selective participation of the bed nucleus of the stria terminalis and CRF in sustained anxiety-like versus phasic fear-like responses. Prog Neuropsychopharmacol Biol Psychiatry (2009) 1.73
Dietary change through African American churches: baseline results and program description of the eat for life trial. J Cancer Educ (2000) 1.73
Efficient export of the vesicular stomatitis virus G protein from the endoplasmic reticulum requires a signal in the cytoplasmic tail that includes both tyrosine-based and di-acidic motifs. Mol Biol Cell (2000) 1.68
Effects of interstimulus interval length and variability on startle-response habituation in the rat. J Comp Physiol Psychol (1970) 1.67
Identification of a form of acyl-CoA:cholesterol acyltransferase specific to liver and intestine in nonhuman primates. J Biol Chem (1998) 1.65
2-year tracking of children's fruit and vegetable intake. J Am Diet Assoc (1998) 1.64
Chromosome translocation can occur on either side of the c-myc oncogene in Burkitt lymphoma cells. Nature (1984) 1.63
Effects of experimental context and explicit threat cues on acoustic startle in Vietnam veterans with posttraumatic stress disorder. Biol Psychiatry (1998) 1.62
Suitability of PSA-detected localised prostate cancers for focal therapy: experience from the ProtecT study. Br J Cancer (2011) 1.62
Cortical afferents to the extended amygdala. Ann N Y Acad Sci (1999) 1.62
Conditioned fear and startle magnitude: effects of different footshock or backshock intensities used in training. J Exp Psychol Anim Behav Process (1978) 1.60
Fear-potentiated startle conditioning in humans: explicit and contextual cue conditioning following paired versus unpaired training. Psychophysiology (1997) 1.59
Mitogen-activated protein kinase cascade in the basolateral nucleus of amygdala is involved in extinction of fear-potentiated startle. J Neurosci (2001) 1.58
Hypothalamic dysfunction in overtrained athletes. J Clin Endocrinol Metab (1985) 1.58
Lesions of the amygdala, but not of the cerebellum or red nucleus, block conditioned fear as measured with the potentiated startle paradigm. Behav Neurosci (1986) 1.57
Normal conditioned inhibition and extinction of freezing and fear-potentiated startle following electrolytic lesions of medical prefrontal cortex in rats. Behav Neurosci (1997) 1.55
A novel extracellular nucleotide receptor coupled to phosphoinositidase-C in pituitary cells. Endocrinology (1990) 1.54
The control of VTEC in the animal reservoir. Int J Food Microbiol (2001) 1.54
Isolation and structure of pro-somatostatin: a putative somatostatin precursor from pig hypothalamus. Proc Natl Acad Sci U S A (1980) 1.54
Agreement between ambulance paramedic- and physician-recorded neurological signs with Face Arm Speech Test (FAST) in acute stroke patients. Stroke (2004) 1.52
Airways in cystic fibrosis are acidified: detection by exhaled breath condensate. Thorax (2002) 1.51
Baseline and fear-potentiated startle in panic disorder patients. Biol Psychiatry (1994) 1.49
Pharmacological and anatomical analysis of fear conditioning using the fear-potentiated startle paradigm. Behav Neurosci (1986) 1.48
A primary acoustic startle pathway: obligatory role of cochlear root neurons and the nucleus reticularis pontis caudalis. J Neurosci (1996) 1.47
A double dissociation in the affective modulation of startle in humans: effects of unilateral temporal lobectomy. J Cogn Neurosci (2001) 1.45
Controlled trial of cysteamine and dimercaprol after paracetamol overdose. Br Med J (1977) 1.45
Inclusion of women in AIDS clinical research: a political and legal analysis. J Am Med Womens Assoc (1994) 1.45
How best to measure implementation of school health curricula: a comparison of three measures. Health Educ Res (1998) 1.45
Early progressive encephalopathy in boys and MECP2 mutations. Neurology (2006) 1.44
Emergency endoscopy after gastrointestinal haemorrhage in 50 patients with portal hypertension. Br Med J (1974) 1.44
Baseline startle amplitude and prepulse inhibition in Vietnam veterans with posttraumatic stress disorder. Psychiatry Res (1996) 1.43
Neurokinin B signaling in the female rat: a novel link between stress and reproduction. Endocrinology (2014) 1.43
Long-term safety of treatment with recombinant human granulocyte colony-stimulating factor (r-metHuG-CSF) in patients with severe congenital neutropenias. Br J Haematol (1994) 1.42
Corticotropin-releasing factor: long-lasting facilitation of the acoustic startle reflex. J Neurosci (1992) 1.42
Urinary D-glucaric acid assay by an improved enzymatic procedure. Clin Chim Acta (1974) 1.42
Carbohydrate absorption from fruit juice in young children. Pediatrics (1995) 1.42
Accelerated development of alcoholic cirrhosis in patients with HLA-B8. Lancet (1982) 1.42
Patient-Reported Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer. N Engl J Med (2016) 1.41
An immunoglobulin heavy chain variable region gene is generated from three segments of DNA: VH, D and JH. 1980. J Immunol (2004) 1.40
Diagnostic yield of fibre-optic endoscopy in the operated stomach. Br J Surg (1973) 1.40
Soft tissue sarcomas involving the pelvis. J Surg Oncol (2001) 1.40
Anxiogenic effects of high illumination levels assessed with the acoustic startle response in rats. Biol Psychiatry (1997) 1.40
Placental structure and inflammation in pregnancies associated with obesity. Placenta (2011) 1.39
Childhood atopic eczema consensus document. S Afr Med J (2005) 1.39
Wound-care training in medical education. J Wound Care (1996) 1.39
Pulmonary manifestations of inhaled street drugs. Heart Lung (1998) 1.39
A distance to the galaxy NGC4258 from observations of Cepheid variable stars. Nature (1999) 1.39
Changing pattern of alcoholic liver disease in Great Britain: relation to sex and signs of autoimmunity. Br Med J (1977) 1.38
Pain pathways involved in fear conditioning measured with fear-potentiated startle: lesion studies. J Neurosci (1999) 1.38
Factors contributing to mortality in paracetamol-induced hepatic failure. Br Med J (Clin Res Ed) (1981) 1.38